Brian Park, PharmD

Drug Information Specialist https://www.clinicalpainadvisor.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

Neuropathic Pain

FDA to Review Capsaicin Patch for Painful Diabetic Peripheral Neuropathy

Brian Park, PharmD

January 10, 2020

A Prescription Drug User Fee Act (PDUFA) target date of July 13, 2020 has been assigned to the application.

Musculoskeletal Pain

Zilretta Labeling Updated to Include Repeat Administration Information for OA Knee Pain

Brian Park, PharmD

January 9, 2020

The product label for Zilretta includes an updated Limitation of Use.

Migraine & Headache

FDA Approves Ubrogepant Tablets for Acute Treatment of Migraine

Brian Park, PharmD

January 9, 2020

The Food and Drug Administration (FDA) has approved Ubrelvy (ubrogepant tablets; Allergan), the first oral calcitonin gene-related peptide (CGRP) receptor antagonist, for the acute treatment of migraine with or without aura in adults. The approval was supported by two pivotal phase 3, randomized, double-blind, placebo-controlled trials (ACHIEVE I and ACHIEVE II) that evaluated the efficacy,…

General Pain

Company Selling Unproven CBD Products Gets Joint Warning Letter

Brian Park, PharmD

October 23, 2019

The claimed their CBD products on their social media website and online store claiming that the products can be used to treat a variety of conditions and diseases including teething pain and earaches in infants, skin problems, autism, ADHD, Parkinson disease, and Alzheimer disease, among others.

Back & Spine Pain

Cell Therapy Receives Fast Track Status for Degenerative Disk Disease

Brian Park, PharmD

August 29, 2019

The FDA has granted Fast Track designation for IDCT (DiscGenics, Inc.), an investigational cell therapy for the reduction in pain and disability associated with degenerative disc disease (DDD).

Next post in Back & Spine Pain

Brian Park, PharmD

All articles by Brian Park, PharmD

FDA to Review Capsaicin Patch for Painful Diabetic Peripheral Neuropathy

Zilretta Labeling Updated to Include Repeat Administration Information for OA Knee Pain

FDA Approves Ubrogepant Tablets for Acute Treatment of Migraine

Company Selling Unproven CBD Products Gets Joint Warning Letter

Cell Therapy Receives Fast Track Status for Degenerative Disk Disease

Atlantoaxial Joint Steroid Injection Improves Neck Pain, Mobility in RA